Junwea Group (China) Co Ltd Overview
| Field | Detail |
|---|---|
| Current legal name (English) | Junwea Group (China) Company Limited |
| Current legal name (Chinese) | 巨美集團(中國)股份有限公司 |
| Stock short name | JUNWEA GROUP (effective 3 June 2026, per HKEX trading arrangement notice dated 1 June 2026) |
| Former names | Hands Form Holdings Limited (恆新豐控股有限公司) – IPO to December 2024; China Wacan Group Company Limited (中國網成集團有限公司, later 中國網成集團股份有限公司) – December 2024 to May 2026 |
| Name change dates | To China Wacan: stock short name changed 13 December 2024 (HKEX notice 10 Dec 2024). To Junwea: special resolution passed at EGM 29 April 2026; Cayman Registrar certificate issued 6 May 2026; short name effective 3 June 2026 |
| Founding year (operating group) | 1989 per Simply Wall St (aggregator). Earliest filing-verified operating history: Adam Cheung joined Pak Fai Engineering in April 1990 (Annual Report 2023 biographies) |
| Listed holding company incorporated | 30 January 2019, Cayman Islands, exempted company (H1 2026 interim results, note 1) |
| Registered office | Windward 3, Regatta Office Park, P.O. Box 1350, Grand Cayman KY1-1108, Cayman Islands |
| Headquarters / principal place of business | Unit 2B, 35/F, East Tower, Cheung Kong Center II, No. 10 Harcourt Road, Central, Hong Kong (Annual Report 2025; H1 2026 interim). Discrepancy: Futu lists "Two International Finance Centre" — the filing address is preferred |
| Prior HQ | Room 9, 2/F, Hang Bong Commercial Centre, 28 Shanghai Street, Jordan, Kowloon (Annual Report 2023) |
| Exchange / ticker | Main Board, Stock Exchange of Hong Kong; stock code 1920 (1920.HK) |
| Listing date | 16 August 2019 |
| ISIN | KYG4288C1015 (from client list; not re-verified post-renaming — ISINs normally persist through name changes) |
| CUSIP | Not applicable / not publicly disclosed |
| Fiscal year end | 31 December |
| Employees | 260 at 31 Dec 2025; ~296 at 30 Jun 2026 (see trend table) |
| Auditor (current) | HLB Hodgson Impey Cheng Limited (appointed 11 December 2025; re-appointed at AGM 29 June 2026) |
| Principal banker | The Bank of East Asia, Limited |
| Company secretary | Mr. Tsui Chun Hung (appointed 30 January 2019) |
| HK share registrar | Boardroom Share Registrars (HK) Limited |
| Controlling shareholder | Mr. Zhou Zhenlin via China Alliance Venture (Technology) Limited — 315,155,000 shares, ~53.63% (MarketScreener, as of 22 April 2026; before the June 2026 placing the stake was higher) |
| Issued shares | 587,600,000 ordinary shares of HK$0.10 each at 30 June 2026 |
| Market capitalisation | ~HK$229.2 M at HK$0.390 per share (Futu quote, 8 September 2026). Not re-verified for 11 October 2026 |
| Website | www.wacan.com.hk (per Annual Report 2025). Legacy: www.handsform.com. |
The entity on the identification list (Hands Form Holdings Limited, 1920.HK, ISIN KYG4288C1015, website handsform.com) still exists as the same Cayman Islands legal entity and same HKEX stock code, but has been renamed twice.
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | H1 2026 |
|---|---|---|---|---|---|
| Employees at period end (headcount, incl. directors) | 16 | 14 | 13 | 260 | 296 |
| Total staff costs (HK$ M) | 5.3 | 5.6 | 5.0 | 15.3 | 24.0 |
Sources: Annual Report 2023 (FY2022–FY2023); Annual Report 2025 (FY2024–FY2025); H1 2026 interim results (staff costs are for the six months only). The roughly twentyfold headcount increase reflects staffing of the Mainland China beauty-and-health stores.
Junwea Group is a Hong Kong-listed micro-cap in transition. For three decades it was a family-controlled wet-trades subcontractor (plastering, tiling, bricklaying, marble works). It operated through Pak Fai Engineering and Ma Yau Engineering, and its customers were Hong Kong main contractors on public and private building projects. After five consecutive years of losses and a revenue collapse from HK$558 M (FY2019) to HK$87 M (FY2023), control passed in early 2025 to Shenzhen-based beauty-industry entrepreneur Zhou Zhenlin. Mr. Zhou then installed a new board and rebranded the company. He launched a franchise-like beauty and health services business in Mainland China, run through 51%-owned joint-venture store subsidiaries with local partners. The Hong Kong construction business still generates about two-thirds of revenue and anchors the company's operating history. However, the strategic narrative, the capital raised and the cost base are now oriented toward Mainland consumer services. The company is loss-making, equity-funded and highly dependent on its controlling shareholder.
Company's own description (Annual Report 2025 and H1 2026 interim)
The company states that it is an investment holding company whose subsidiaries are principally engaged in three businesses: (i) beauty and health services; (ii) construction services, comprising wet trades works (plastering of floors, walls and ceilings; tiling of internal and external walls and floors; bricklaying; marble works) and related ancillary works; and (iii) construction information technology services. The H1 2026 interim results list the beauty and health segment first, which signals management's reprioritisation. The FY2025 report described the beauty business as delivering facial treatments, blemish removal, skin whitening and anti-wrinkle services through physical stores in first- and second-tier Mainland cities.
Independent characterisation
In economic substance the group currently runs two unrelated businesses under one listed shell:
-
A sub-scale, project-driven Hong Kong finishing-trades subcontractor (Ma Yau Engineering). It wins fixed-price tenders of 1–17 months' duration from main contractors (H1 2026 interim, note 3A). It recognises revenue over time using an input (cost-to-cost) method. Its margin profile is exposed to tender pricing, variation-order recovery and the timing of works certification. Gross margins were negative from FY2021 to FY2024 and only turned positive in FY2025 because of project final-account settlements.
-
A start-up Mainland beauty-salon network. It operates through majority-owned (typically 51%/49%) local subsidiaries co-owned with regional partners. The model combines services with product sales (product revenue is recognised on delivery) and appears to rely on prepaid customer balances. Contract liabilities rose to HK$39.5 M at 30 June 2026, and the company itself flags prepaid-card regulation as a risk. The segment lost HK$10.3 M on HK$25.6 M of revenue in H1 2026.
A third activity, a subscription construction-IT platform, is immaterial. It generated HK$366,000 in each of FY2023 and FY2024 and nil in H1 2025 and H1 2026.
Revenue model mix
| Revenue model | Segment | Approx. share of revenue (H1 2026) | Notes |
|---|---|---|---|
| Project/contract revenue (fixed-price, recognised over time) | Construction services | 68% (HK$54.3 M of HK$79.9 M) | Input method; retention typically held for a 12-month defects liability period |
| Consumer services and product sales | Beauty and health | 32% (HK$25.6 M) | Product sales recognised on delivery; service revenue presumably on consumption of prepaid balances (policy detail not fully disclosed) |
| Subscription (fixed monthly billing) | Construction IT | 0% | Practical expedient: revenue recognised as invoiced |
| Licensing | — | 0% | None disclosed |
Value-chain position, customers and end-markets
| Dimension | Construction services | Beauty and health |
|---|---|---|
| Value-chain position | Tier-2 specialist trade subcontractor below main contractors | Store operator (via 51%-owned JVs); also sells products |
| Direct customers | Hong Kong main contractors and other subcontractors | Retail consumers (predominantly female, urban) |
| Ultimate project owners | Predominantly government entities and property developers (Futu company profile, derived from prospectus) | — |
| Public vs private mix | H1 2026: public HK$20.3 M, private HK$34.1 M; H1 2025: public HK$57.7 M, private HK$7.3 M | Private (consumer) |
| Concentration | FY2025: largest customer 40.7% of group revenue; top five 91.5% | — |
| Geography | Hong Kong | Mainland China — Shenzhen, Beijing, Shanghai, Wuhan, Fuzhou, Chongqing, Shenyang, Xi'an and others |
| Regulatory registration | CIC Registered Specialist Trade Contractors Scheme (finishing wet trades; marble, granite and stone work) | PRC beauty-services and prepaid-card regulations (company-flagged) |
Strategy
Stated strategy themes (Annual Report 2025; H1 2026 interim)
-
Diversification into beauty and health. Management argues that rising health awareness and the consumer pursuit of beauty create large opportunities, and that the new business diversifies revenue sources.
-
Partner-led expansion model. Local partners with regional beauty-industry experience and customer networks co-own store subsidiaries (51/49), which management says creates synergies and upgrades the business model.
-
Conservative stance in construction. Management maintains market share, monitors the market, competes on quality, and seeks to expand its customer base and win more wet-trades projects despite sluggish Hong Kong construction activity.
-
Geographic expansion beyond Hong Kong and the PRC. This is exploratory and no market has been named.
-
Shareholder returns through diversification. Management expects diversification to provide better returns to shareholders.
Initiatives in the last 24 months
| Initiative | Date | Detail | Targets / status |
|---|---|---|---|
| Change of control and board overhaul | Jan–May 2025 | Zhou acquires control; founders exit | Completed |
| Beauty and health launch | 2,025 | 67 stores via JVs | Ongoing; segment loss HK$10.3 M in H1 2026 |
| Use of June 2025 placing proceeds | 2,025 | HK$8.1 M to set up ~8 beauty stores in tier-1 cities; HK$3.0 M office renovation; HK$3.0 M working capital | Fully utilised by 31 Dec 2025 |
| Use of subscription proceeds (net HK$43.9 M) | Apr 2026 | HK$30.73 M construction services; HK$8.78 M working capital; HK$4.39 M beauty R&D | Construction and working-capital amounts fully used by 30 Jun 2026; R&D to be used by Dec 2026 |
| Use of June 2026 placing proceeds (net HK$32.5 M) | Jun 2026 | 70% (HK$22.75 M) for two potential new wet-trades projects; 30% (HK$9.75 M) working capital including rent and management salaries | Unutilised at 30 Jun 2026; to be deployed in H2 2026 |
| Rebranding to Junwea (巨美, roughly "great beauty") | Apr–Jun 2026 | Name aligns with the beauty pivot | Completed |
| New share scheme | Feb 2026 | Replaces the 2019 option scheme | No grants as of the AR2025 date |
| Authorised capital tripled | Feb/Jun 2026 | HK$40 M → HK$120 M (1.2 bn shares) | Completed; leaves room for further issuance |
| Cost programmes | — | None disclosed | — |
Analyst observation: despite the beauty-oriented narrative, 70% of the June 2026 placing proceeds and 70% of the subscription proceeds were allocated to the construction business. This suggests the construction segment's working-capital needs remain acute, which is consistent with the HK$45.0 M of unbilled contract assets.
Guidance and medium-term targets
None disclosed. The company provides no quantitative revenue, margin or store-count guidance.
ESG commitments
Generic statements only (energy-saving equipment, waste reduction). Quantitative targets are not disclosed.
Products & Services
Construction services (Ma Yau Engineering)
| Offering | Description | Specification / capability | Target customer | Since | Pricing model |
|---|---|---|---|---|---|
| Plastering | Plastering of floors, walls and ceilings | Includes spray plaster and screeding | HK main contractors | Registered 2004 | Fixed-price contract, input-method revenue |
| Tiling | Tile laying on internal and external walls and floors | Ceramic and porcelain tiling | Same | 2,004 | Same |
| Bricklaying | Brick and block work | — | Same | 2,004 | Same |
| Marble and granite works | Marble, granite and stone works | Registered under the "Tiling of Marble and Granite Tiles and Stonework" category | Same | 2,004 | Same |
| Ancillary wet-trades works | Related ancillary services | Not itemised | Same | — | Same |
Contract terms: fixed price, 1–17 months' duration; retention typically released after a 12-month defects liability period (H1 2026 interim, notes 3A and 15). Flagship projects are not named in recent filings, apart from references to delayed projects in Tai Wai and the Islands District (FY2023 and FY2025 reports).
Construction IT services
| Offering | Description | Target customer | Launch | Pricing |
|---|---|---|---|---|
| Wet-trades payment-application platform | Online database of specifications for wet-trades service items to help subscribers review contractors' monthly payment requests and calculate work done | Wet-trades service providers unfamiliar with payment applications | 2,021 | Fixed monthly subscription |
Beauty and health services (Mainland China)
| Offering | Description | Delivery | Target customer | Launch | Pricing |
|---|---|---|---|---|---|
| Facial treatments | Facial care services | Physical stores | Urban consumers in tier-1/2 cities | 2,025 | Not disclosed (prepaid balances implied) |
| Blemish removal | Spot/blemish treatment | Physical stores | Same | 2,025 | — |
| Skin whitening | Whitening treatments | Physical stores | Same | 2,025 | — |
| Anti-wrinkle services | Anti-ageing treatments | Physical stores | Same | 2,025 | — |
| Beauty and health products | Retail product sales (inventory of HK$2.5 M at 30 Jun 2026) | Stores | Same | 2,025 | Point-of-sale; recognised on delivery |
Network: 67 stores established with local partners as of the FY2025 annual report (dated 31 March 2026), in Shenzhen, Beijing, Shanghai, Wuhan, Fuzhou, Chongqing, Shenyang, Xi'an and other cities. The H1 2026 interim refers to stores "in nine PRC cities" without restating a store count. Brand names, store-level unit economics, membership counts and price lists are not publicly disclosed. The H1 2026 interim mentions R&D funding for the beauty and health business (HK$4.39 M allocated, unused), but no named product or platform has been disclosed.
Financial Narrative
Income statement
Sources: FY2022 annual results (FY2021–FY2022 revenue, gross loss, loss before tax); MT Newswires (FY2021 net loss); Annual Report 2023 (FY2022–FY2023 admin and finance costs); FY2024 annual results (FY2023–FY2024 income statement); Annual Report 2025 (FY2025). EBITDA and operating income are not reported as such. The non-controlling-interest deficit of HK$4.4 M at 31 Dec 2025 implies roughly HK$4.4 M of 2025 losses attributable to minority partners (derived).
Earlier history for context: revenue was HK$558.1 M in FY2019 and HK$305.0 M in FY2020 (FY2020 results announcement).
Per-share data
Notes: FY2021 (HK$0.032) and FY2022 (HK$0.0195) were reported before the August 2023 10:1 consolidation. The adjusted values (×10) are derived. Diluted equals basic because there were no dilutive instruments outstanding. No dividends have been declared since listing; distributable reserves were nil at 31 Dec 2023, 2024 and 2025.
Margins and growth
Derived from 6.1. FY2021 growth uses the FY2020 base of HK$305.0 M. Revenue CAGR FY2021–FY2025: +1.5% p.a. (derived). Revenue CAGR FY2019–FY2025: −22.1% p.a. (derived).
Balance sheet: notes and sources
Sources: FY2024 annual results (FY2023–FY2024 balance sheets); Annual Report 2023 (cash and borrowings FY2022–FY2023); Annual Report 2025 (cash and borrowings FY2025); H1 2026 interim (31 Dec 2025 comparatives). FY2022 equity is derived from bank borrowings of HK$9.7 M divided by the reported gearing of 9.3%, so treat it as approximate. No goodwill or intangibles appear in the line items reviewed. Lease liabilities at FY2025 = HK$2.965 M current + HK$5.127 M non-current. FY2021 share capital of HK$26.0 M is derived (2.6 bn shares at HK$0.01). FY2022 share capital reflects 3.12 bn shares after the June 2022 placing.
Interim balance sheet snapshot: notes and sources
Source: H1 2026 interim results. Observation: gross contract assets rose from HK$30.1 M to HK$71.5 M against an impairment allowance of HK$21.2 M. Unbilled revenue alone was HK$45.0 M at 30 June 2026, meaning works completed but not yet verified by customer representatives. This is the single largest balance-sheet judgement and is consistent with management's statement that certification was delayed.
Cash flow
Equity raised: June 2022 placing (520 M × HK$0.03); June 2025 placing (62.4 M × HK$0.241 = HK$15.0 M gross; HK$14.1 M net). No buybacks were made in any year reviewed (Annual Reports 2023 and 2025).
2026 year-to-date equity raised: HK$44.5 M subscription + HK$11.8 M option exercise (26 M × HK$0.453, derived) + HK$33.0 M placing = ~HK$89.3 M gross, which exceeds the cumulative equity raised over the prior six years.
Ratios
All ratios derived from tables 6.1 and 6.4 except gearing, which is as reported. Gearing definitions changed: FY2022–FY2023 = bank borrowings / equity; FY2024–FY2025 = bank borrowings + lease liabilities + amount due to related company / equity. Gearing fell to 20.4% at 30 June 2026. Interest coverage is not meaningful because operating results were losses. ROIC, net debt/EBITDA and cash conversion cycle cannot be computed from the verified disclosures.
Half-year comparison: notes and sources
Source: H1 2026 interim results. Discrepancy: the H1 2026 MD&A text states that net loss attributable to owners was ~HK$27.1 M, while the income statement shows HK$20.0 M attributable to owners and HK$27.1 M for the group in total. The LPS of 4.60 cents reconciles to the HK$20.0 M owners' figure (20,036 / 435,415 thousand weighted shares). The income statement figures are preferred.
Commentary on trends, inflections and drivers
Revenue. Revenue fell from HK$558 M in FY2019 to HK$87 M in FY2023, an 84% decline in four years. The filings attribute this to intense tender competition, including the entry of Mainland construction firms into the Hong Kong market, fewer successful tenders and lower contract values (Annual Report 2023). The partial recovery in FY2024–FY2025 (+27%, then +14%) reflected more successful tenders. In FY2025, HK$8.9 M came from the new beauty segment, so organic construction growth was only about 5%. In H1 2026 construction revenue fell 16.5% year on year, and group growth (+22.9%) came entirely from the beauty segment.
Gross margin. Gross margin was negative for four straight years (FY2021–FY2024). The causes were competitive pricing, unrecovered costs from customer-initiated site changes, additional subcontracting and delays, notably on Tai Wai projects (Annual Report 2023). The FY2025 inflection to +8% was explicitly attributed to final-account settlements on certain projects, which are non-recurring by nature. H1 2026 reverted to a margin of 1.1%. Our assessment: the construction business has not demonstrated a sustainable positive gross margin since at least FY2020.
Cost base. Administrative expenses tripled in FY2025 (to HK$26.7 M from HK$8.9 M) and roughly tripled again on a run-rate basis in H1 2026 (HK$27.5 M in six months). The drivers were professional fees, staff and rent, including the Central HQ lease at about HK$4.0 M a year. The fixed-cost structure is now that of a holding company with a national retail network, while gross profit remains that of a small subcontractor.
Impairments. Expected-credit-loss charges were a major loss driver in FY2024 (HK$21.5 M). FY2025 benefited from a HK$2.3 M reversal, of which HK$1.9 M related to Tai Wai and Islands District projects. The cumulative allowance on contract assets of HK$21.2 M at 30 June 2026 represents 30% of gross contract assets.
Balance sheet. Equity eroded from roughly HK$104 M (FY2022, derived) to HK$9.8 M (FY2024) through accumulated losses, then was rebuilt through issuance to HK$75.9 M at 30 June 2026. The company carried no bank debt at either 31 Dec 2025 or 30 Jun 2026.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Segment Overview
| Segment | Contents | Principal entity | Status |
|---|---|---|---|
Beauty and health services | Facial treatments, blemish removal, skin whitening, anti-wrinkle services; beauty and health product sales | Local PRC subsidiaries, typically 51% group / 49% local partner | New in 2025; first segment listed in 2026 |
Construction services | Wet trades works and ancillary works in Hong Kong | Ma Yau Engineering Limited (Pak Fai Engineering was referenced through 2023 but no longer in 2025 reports — its current status is not disclosed) | Legacy core |
Construction IT services | Online database/platform assisting monthly review of contractors' payment applications | Not separately named | Dormant (nil revenue in H1 2025 and H1 2026) |
Segment revenue (HKD Mn)
| Segment revenue (HKD Mn) | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Construction services | 86.3 | 109.6 | — |
Construction IT services | 0.4 | 0.4 | — |
Construction services + IT combined | 86.7 | 110.0 | 116.0 |
Beauty and health services | 0 | 0 | 8.9 |
Total revenue | 86.7 | 110.0 | 124.9 |
Revenue by Segment
| Segment metric (HKD Mn) | H1 2025 | H1 2026 |
|---|---|---|
Construction services revenue | 65.1 | 54.3 |
Beauty and health revenue | 0 | 25.6 |
Construction IT revenue | 0 | 0 |
Total revenue | 65.1 | 79.9 |
Construction services segment result | 2.0 | -7.6 |
Beauty and health segment result | 0 | -10.3 |
Unallocated corporate expenses | -1.8 | -9.1 |
Profit/(loss) before tax | 0.1 | -26.9 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansSegment Margins & Growth (%) and Revenue by Segment (%)
| Ratio (%) | H1 2025 | H1 2026 |
|---|---|---|
Construction segment margin | 3.0 | -14.0 |
Beauty and health segment margin | — | -40.1 |
Construction share of revenue | 100.0 | 68.0 |
Beauty and health share of revenue | 0 | 32.0 |
Construction revenue YoY growth | — | -16.5 |
Income Statement
| Metric (HKD Mn) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Revenue | 117.5 | 122.5 | 86.7 | 110.0 | 124.9 |
Gross profit | -63.5 | -28.6 | -21.5 | -12.9 | 10.0 |
Administrative expenses | — | 7.9 | 9.1 | 8.9 | 26.7 |
ECL impairment (charge)/reversal | — | — | — | -21.5 | 2.3 |
Finance costs | — | 0.3 | 0.3 | 0.2 | 0.5 |
Loss before tax | -83.1 | -56.3 | -51.6 | -43.3 | — |
Net loss attributable to owners | -83.2 | -56.2 | -51.6 | -43.3 | -14.5 |
Per-Share Data
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Basic/diluted LPS (HK cents, consolidation-adjusted) | -32.0 | -19.5 | -16.54 | -13.89 | — |
Dividend per share (HK cents) | 0 | 0 | 0 | 0 | 0 |
Margin Analysis (%)
| Ratio (%) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Gross margin | -54.0 | -23.4 | -24.8 | -11.7 | 8.0 |
Net margin (owners) | -70.8 | -45.9 | -59.5 | -39.4 | -11.6 |
Revenue growth YoY | -61.5 | 4.3 | -29.2 | 26.9 | 13.6 |
Admin expense / revenue | — | 6.4 | 10.5 | 8.1 | 21.4 |
Balance Sheet
| Metric (HKD Mn) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Total assets | — | — | 71.8 | 42.3 | 62.8 |
Current assets | — | — | 64.1 | 36.5 | 49.8 |
Current liabilities | — | — | 18.6 | 32.4 | 43.5 |
Net current assets (working capital) | — | — | 45.5 | 4.0 | 6.3 |
Cash and bank balances | — | 14.0 | 18.6 | 10.5 | 31.1 |
Bank borrowings and overdrafts | — | 9.7 | 9.6 | 5.3 | 0 |
Lease liabilities | — | — | — | — | 8.1 |
Net debt (bank debt minus cash) | — | -4.3 | -9.0 | -5.2 | -31.1 |
Total equity | — | 104.3 | 53.2 | 9.8 | 14.2 |
Equity attributable to owners | — | 104.3 | 53.2 | 9.8 | 18.6 |
Goodwill and intangibles | — | — | 0 | 0 | 0 |
Issued share capital | 26.0 | 31.2 | 31.2 | 31.2 | 37.4 |
Balance Sheet (31 Dec 2025–30 Jun 2026)
| Line item (HKD K) | 31 Dec 2025 | 30 Jun 2026 |
|---|---|---|
Property, plant and equipment | 10,116 | 7,113 |
FVTPL (key-man life policy) | 2,911 | 2,947 |
Trade receivables | 230 | 7,753 |
Other receivables, deposits, prepayments | 7,883 | 5,838 |
Contract assets (net) | 9,444 | 50,316 |
Inventories | 1,097 | 2,491 |
Cash and cash equivalents | 31,117 | 57,343 |
Total assets | 62,798 | 133,801 |
Trade and other payables | 9,306 | 8,219 |
Contract liabilities | 29,198 | 39,500 |
Amount due to related company | 2,000 | 3,182 |
Lease liabilities (total) | 8,092 | 6,958 |
Net assets | 14,202 | 75,942 |
Equity attributable to owners | 18,648 | 87,538 |
Non-controlling interests | -4,446 | -11,596 |
Balance Sheet — Dividends paid
| Metric (HKD Mn) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Dividends paid | 0 | 0 | 0 | 0 | 0 |
Share buybacks | 0 | 0 | 0 | 0 | 0 |
Equity raised (gross) | 0 | 15.6 | 0 | 0 | 15.0 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
ROE (%) — owners' loss / average owners' equity | — | -65.5 | -137.4 | -102.1 |
ROA (%) — owners' loss / average total assets | — | — | -75.9 | -27.6 |
Current ratio (x) | — | 3.45 | 1.12 | 1.15 |
Company-defined gearing (%) | 9.3 | 18.1 | 54.0 | 71.1 |
Asset turnover (x) | — | — | 1.93 | 2.38 |
Income Statement and Margin Analysis (%)
| Metric (HKD Mn) | H1 2025 | H1 2026 |
|---|---|---|
Revenue | 65.1 | 79.9 |
Cost of services | -56.8 | -79.1 |
Gross profit | 8.3 | 0.9 |
Gross margin (%) | 12.7 | 1.1 |
Administrative expenses | -8.1 | -27.5 |
Profit/(loss) for period | 0.1 | -27.1 |
Attributable to owners | 0.1 | -20.0 |
Attributable to NCI | 0 | -7.0 |
Basic LPS (HK cents) | 0.04 | -4.60 |
Staff costs | 2.5 | 24.0 |
Short-term lease expense | 0.5 | 6.8 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansRegion revenue (HKD Mn)
| Region revenue (HKD Mn) | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Hong Kong | 86.7 | 110.0 | 116.0 |
Mainland China | 0 | 0 | 8.9 |
Total | 86.7 | 110.0 | 124.9 |
Region revenue (HKD Mn) (Half-Yearly)
| Region revenue (HKD Mn) | H1 2025 | H1 2026 |
|---|---|---|
Hong Kong | 65.1 | 54.3 |
Mainland China | 0 | 25.6 |
Region growth (%)
| Region growth (%) | FY2024 | FY2025 | H1 2026 YoY |
|---|---|---|---|
Hong Kong | 26.9 | 5.5 | -16.5 |
HK construction revenue by sector (HKD Mn)
| HK construction revenue by sector (HKD Mn) | H1 2025 | H1 2026 |
|---|---|---|
Public sector projects | 57.7 | 20.3 |
Private sector projects | 7.3 | 34.1 |
Share count (M)
| Share count (M) | FY2019 | FY2022 | FY2023 | FY2024 | FY2025 | Jun 2026 |
|---|---|---|---|---|---|---|
Issued shares at period end (millions) | 2,600 | 3,120 | 312 | 312 | 374.4 | 587.6 |
Share Price & Returns
| Reference point | Price (HKD) | Source |
|---|---|---|
Implied IPO price (Aug 2019, pre-consolidation) | ~0.20 (≈2.00 post-consolidation) | — |
June 2022 placing (pre-consolidation) | 0.03 (≈0.30 post-consolidation) | MT Newswires |
MGO offer price (Jan 2025) | 0.2565 | Joint announcement |
June 2025 placing | 0.241 | AR2025 |
Option exercise price (Sep 2025 grant) | 0.453 | AR2025 |
Subscription price (Nov 2025) | 0.3965 | AR2025 |
June 2026 placing | 0.441 | H1 2026 interim |
Close on 15 Jun 2026 | 0.50 | H1 2026 interim |
8 Sep 2026 | 0.390 | Futu |
Performance | Value | Note |
5-year / since IPO | Roughly −80% (HK$0.39 vs ≈HK$2.00 consolidation-adjusted implied IPO price) | Derived; indicative only |
Valuation Multiples
| Multiple | Junwea |
|---|---|
Market capitalisation (HKD Mn) | 229.2 |
Enterprise value (HKD Mn) | ~179 (market cap − cash 57.3 + lease liabilities 7.0) |
TTM revenue (HKD Mn) | 139.7 (FY2025 124.9 − H1'25 65.1 + H1'26 79.9) |
TTM owners' loss (HKD Mn) | −34.6 |
P/E | Not meaningful (loss) |
EV/Sales | ~1.3x |
P/B (owners' equity HK$87.5 M) | ~2.6x |
P/S | ~1.6x |
Capital Markets
| Item | Status |
|---|---|
Sell-side coverage | None identified. |
Dividend history | No dividends since IPO; no distributable reserves at 31 Dec 2023, 2024 or 2025 |
Dividend policy | Board considers financial condition, capital and debt levels, cash needs, lender restrictions and market conditions; no payout ratio (AR2025) |
Buyback authorisation | 10% general repurchase mandate renewed 29 Jun 2026; no repurchases executed |
Issuance mandate | 20% general issuance mandate renewed 29 Jun 2026 |
Credit ratings (Moody's / S&P / Fitch) | Not rated |
Debt maturity profile | No bank debt. Lease liabilities of HK$7.0 M (HK$3.7 M current, HK$3.2 M non-current) at 30 Jun 2026 |
Analyst Conclusions
Management guidance
No quantitative guidance. Qualitative messages from the H1 2026 interim: a conservative approach to Hong Kong construction amid a sluggish market; continued pursuit of wet-trades projects (two specific potential awards targeted); continued development of Mainland beauty and health stores with local partners; exploration of markets beyond Hong Kong and the PRC; and deployment of HK$32.5 M of June 2026 placing proceeds in H2 2026.
Consensus expectations
No consensus estimates exist.
Bull case
-
Beauty run-rate inflection. Segment revenue went from HK$8.9 M (FY2025) to HK$25.6 M (H1 2026). If the 67-store base matures and segment losses narrow from −40%, the segment could plausibly become the larger business within two years and justify a consumer-services multiple.
-
Clean balance sheet funds both legs. No bank debt, HK$57.3 M of cash, HK$32.5 M of unspent placing proceeds and a backlog of HK$219.2 M give the company runway, with project awards as catalysts.
-
Insider alignment. The controlling shareholder injected HK$44.5 M at HK$0.3965 and exercised options at HK$0.453, both above the current price, signalling confidence and making a value-destructive exit less likely in the near term.
Bear case
-
No profitable core. Construction gross margin was negative in four of the last five years and only 1.1% in H1 2026. The beauty segment loses HK$0.40 per HK$1 of revenue. Combined with HK$9 M of unallocated head-office costs per half-year, there is no visible path to breakeven.
-
Serial dilution. The share count rose 88% in about 12 months, authorised capital tripled and a 20% mandate is in place. Equity funds losses rather than compounding.
-
Governance and earnings-quality flags. Three auditor changes in five years, a late discloseable-transaction notice, a loss-attribution mismatch in the interim MD&A, HK$45 M of unbilled contract assets with a 30% allowance on gross contract assets, related-party advances and subleases, and a −HK$11.6 M NCI deficit signal elevated reporting risk.
Catalysts and monitorables (next 12 months)
| Monitorable | Why it matters | Timing |
|---|---|---|
| Award of the two targeted wet-trades projects | Validates the use of 70% of placing proceeds | H2 2026 |
| Certification and billing of HK$45.0 M unbilled contract assets | Cash conversion; impairment risk | H2 2026 |
| Store count and segment loss in FY2026 results | Tests beauty unit economics | March 2027 |
| Contract liabilities trend vs PRC prepaid-card rules | Regulatory and cash-flow exposure | Ongoing |
| Further equity issuance under the 20% mandate | Dilution | Any time |
| Auditor continuity and FY2026 audit opinion | Reporting quality | March 2027 |
| Related-party transactions with Zhou-linked entities | Minority-shareholder protection | Ongoing |
| Deployment of HK$4.39 M beauty R&D allocation | Execution against stated plan | By Dec 2026 |
Analyst verdict
Junwea Group is best understood as a listed platform in the middle of a reverse-transition. A failing Hong Kong subcontractor is being repurposed by a new controlling shareholder into a Mainland beauty-and-health consumer business, while the legacy construction operation is kept alive to sustain revenue and listing credibility. The facts are unambiguous on several points. Revenue is about 78% below its FY2019 peak. The construction business has not shown a durable positive gross margin since at least FY2020. The company has lost money attributable to shareholders in every full year since FY2021, cumulatively roughly HK$249 M. Since control changed, the cost base has scaled up far faster than gross profit: administrative expenses ran at about HK$55 M annualised in H1 2026 against gross profit of under HK$1 M.
The counterweights are real but modest. The balance sheet has been recapitalised with about HK$89 M of 2026 equity. There is no bank debt. The controlling shareholder has put his own money in at prices close to today's. The beauty segment is growing quickly from a small base. The construction backlog of HK$219 M also gives some revenue visibility, although the shrinking tender pipeline (HK$97.9 M across three bids) argues against expecting growth.
At about 1.3x EV/TTM sales and 2.6x book value, the market is already paying a premium to tangible equity for an unproven turnaround. That premium is hard to justify given the governance record: three auditor changes, disclosure lapses, related-party arrangements and an interim-report inconsistency on loss attribution. Investors should treat this as a special-situation, controller-dependent micro-cap rather than an operating-business investment. Our stance is cautious / avoid for fundamental investors. The thesis would turn constructive only on evidence of beauty-segment breakeven at the store level, sustained positive construction gross margins without final-account one-offs, and a full fiscal year without further dilutive issuance or reporting irregularities.
End of dossier. All figures are from the cited filings or aggregators. "Derived" values are arithmetic computations from disclosed figures and should be read as approximations.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Role | Appointed | Age (AR2025) | Background | Education |
|---|---|---|---|---|---|
Zhou Zhenlin (周振林) | Chairman, Executive Director, controlling shareholder; Chairman of Nomination Committee | ED 6 Sep 2024; Chairman/President 30 Oct 2024 | 45 | Deputy GM, Shenzhen Jiameiran Technology (skincare/beauty devices, 2004–2011); President, Shenzhen Runfei Technology (2012–2017); Chairman, Tofuls International Holdings Group (health and wellness consulting, since 2017); Chairman, World Chinese Business (Guangdong) Technology (since 2023); Chairman, Shihua International Club (since 2023); Chairman, Global Chinese Business Club (since Jan 2026, per MarketScreener) | Executive DBA, University of Montpellier (2025); business administration course, Guangxi University Business School (2003) |
Peng Yunying (彭運英) | Executive Director; President | 16 May 2025 | 56 | Vice chairman, Global Chinese Merchants Club (Guangdong); Avon beauty salon store manager (1997–2006); GM of a Shenzhen beauty centre (2006–2012); technical director, Shenzhen Runfei (2012–2017); vice chairman, Tofuls International (2017–2023) | Bachelor's in business administration, Open University of China (2021) |
Guo Xianjiao (郭顯教) | Executive Director | 16 May 2025 | 56 | Vice chairman, Global Chinese Merchants Club (Guangdong); brand manager, Sibao Industrial (1997–2001); brand director, Jianlibao Group (2002–2004); principal of a Wuhan vocational school (2004–2012); president, Guangdong Tongfu Education Technology (2019–2023). Director's fee HK$8,000/month | MBA, Wuhan University (2009) |
Ding Xin (丁昕) | INED; Chair of Audit Committee | 1 Apr 2022 | 38 | HKICPA member since 2014; 15+ years in audit and financial management; sole proprietor of a CPA practice (AR2023) | BBA (Accounting and Finance), University of Hong Kong |
Zhang Lingke (張菱珂) | INED | Not stated in extracted text (in office throughout 2025) | 36 | Cabin attendant, Shenzhen Airlines (2010–2015); KLM flight attendant (2015–2021); risk-control specialist at a Ningbo private equity fund manager (2022–2024) | Flight-attendant programme, Civil Aviation Flight University of China; part-time law programme, Sichuan University |
Prof. Lam Sing Kwong, Simon (林誠光) | INED; Chair of Remuneration Committee | 16 May 2025 | 66 | Professor of management and strategy, HKU Business School (since 2006); INED of Jacobson Pharma (2633), Kwan On Holdings (1559), OCT (Asia) (3366) and Qingci Games (6633) | MSc, University of Essex; PhD (Commerce), Australian National University |
Directors' Remuneration
| Item | Detail |
|---|---|
Board size | 6 (3 executive, 3 independent non-executive) |
Independence | 50% INEDs (meets the Listing Rule 3.10A one-third minimum) |
Chair/CEO separation | Chairman Zhou; President Peng. Historically, Adam Cheung combined Chairman and CEO roles, a disclosed deviation from CG Code C.2.1 |
Audit Committee | Ding Xin (Chair), Zhang Lingke, Lam Sing Kwong — all INEDs |
Remuneration Committee | Lam Sing Kwong (Chair), Ding Xin, Zhang Lingke |
Nomination Committee | Zhou Zhenlin (Chair), Ding Xin, Zhang Lingke, Lam Sing Kwong |
Board meetings FY2025 | 24 (Annual Report 2025) |
Gender diversity | 3 of 6 directors female at the H1 2026 date (Peng, Ding, Zhang). Note: AR2025 states "two female and five male Directors", which is internally inconsistent with a 6-member board |
Workforce gender ratio | ~7:1 male to female (AR2025 — likely carried over from the construction-only era; stale given beauty-store hiring) |
Internal audit | No separate internal audit function; external consultant reviewed controls |
Directors' Remuneration — Key management compensation H1 2026
| Item | Amount | Source |
|---|---|---|
Key management compensation H1 2026 (short-term + post-employment) | HK$771,000 | H1 2026 interim, note 18 |
Key management compensation H1 2025 | HK$915,000 | H1 2026 interim, note 18 |
Guo Xianjiao director's fee | HK$8,000/month | AR2025 |
Options granted 2 Sep 2025 | Zhou 3,744,000; Peng 1,872,000; Guo 1,684,800; 18 employees 18,699,200; exercise price HK$0.453; fair value HK$0.18–0.20 per option | AR2025 |
Major Shareholders
| Holder | Shares | % | Date / source |
|---|---|---|---|
China Alliance Venture (Technology) Limited (100% owned by Zhou Zhenlin) | 199,091,000 | 63.81% of 312 M | 31 Dec 2025 (AR2025; offer close 30 Apr 2025) |
Same, after subscription | 311,411,000 | 63.98% (stated in AR2025 on an enlarged-share basis) | AR2025 |
Zhou Zhenlin (aggregate incl. option shares) | 315,155,000 | 53.63% of 587.6 M | 22 Apr 2026 (MarketScreener) |
Public float (incl. placees) | ~272.4 M | ~46.4% | Derived |
Competitive Landscape
Key Competitors
| Competitor type | Examples | Relative positioning |
|---|---|---|
Unlisted RSTCS-registered wet-trades subcontractors | ~530 registrants (names not disclosed in accessible filings) | Price-competitive; lower overheads than a listed issuer |
Mainland construction enterprises entering Hong Kong | Not named in filings | Cited by management as compressing tender prices and margins (AR2023) |
Listed HK specialist and finishing subcontractors | — | Similar scale challenges |
Key Competitors by Competitor
| Competitor | Listing | Scale indicator | Positioning vs Junwea |
|---|---|---|---|
Beauty Farm Medical and Health Industry (BFG Meitian Group) | 2373.HK | 1.13 M client visits at direct beauty and wellness stores in H1 2026 (+33%); H1 2026 net profit +40% (PRNewswire, 28 Aug 2026) | Category leader; integrated "dual beauty + dual wellness" model; scale and profitability far exceed Junwea |
Naturade (Guangzhou Naturade Health Management) | Acquired by Beauty Farm | Integrated 150 stores (Beauty Farm H1 2024 results) | Consolidated into the leader |
CellCare (Meitian Medical) | Beauty Farm brand | Medical aesthetics arm | Higher-acuity services |
Independent and franchise salon chains | Mostly unlisted | Fragmented | Direct competition at store level |
Medical aesthetics clinics | Various | — | Overlap in anti-wrinkle and whitening treatments |
Competitor Detail
| Metric | Junwea (FY2025 / H1 2026) |
|---|---|
Revenue | HK$124.9 M (FY2025) |
Revenue growth | +13.6% (FY2025); +22.9% (H1 2026) |
Gross margin | 8.0% (FY2025); 1.1% (H1 2026) |
Net margin | −11.6% (FY2025, owners) |



